Universe Pharmaceuticals (UPC) is up 96.5% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver is continued buying interest around Universe Pharmaceuticals’ planned all-stock acquisition of Best Praise International, a transaction that would add five pharmaceutical patents in China to its portfolio. Given the stock’s very heavy trading volume and small-cap profile, momentum trading appears to be amplifying the reaction.
Details:
Sources:
SEC, GlobeNewswire, Nasdaq
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$UPC Hedge Fund Activity
We have seen 0 institutional investors add shares of $UPC stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 946 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2,601
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.